News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sangamo Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Down Syndrome’s Extra Chromosome Silenced, University of Massachusetts Medical School, Sangamo BioSciences, Inc. Study
July 18, 2013
·
5 min read
Drug Development
Double Whammy Gene Therapy Clears HIV From Body, Sangamo BioSciences, Inc. Reveals
September 23, 2011
·
1 min read
Drug Development
New AIDS Approach Disrupts Patient’s DNA, Sangamo BioSciences, Inc. Announces
February 3, 2009
·
1 min read
Biotech Beach
The Week In Review: Biotech Treks Higher
February 5, 2007
·
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
·
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
·
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
·
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Another Biotech
April 7, 2006
·
1 min read
Biotech Beach
Sangamo BioSciences, Inc. Reports Success Using ZNPs To Fight Aids
December 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
December 19, 2025
·
6 min read
Press Releases
Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy
December 3, 2025
·
6 min read
Press Releases
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
November 24, 2025
·
6 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
November 7, 2025
·
17 min read
Press Releases
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call
October 31, 2025
·
1 min read
Press Releases
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
September 5, 2025
·
11 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
August 8, 2025
·
17 min read
Press Releases
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
August 1, 2025
·
1 min read
Press Releases
Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
June 24, 2025
·
10 min read
Press Releases
Messenger RNA Market Research Report 2025-2035, Competitive Analysis of Pfizer, GSK, Arcturus Therapeutics, AstraZeneca, Beam Therapeutics, Moderna, Oncotelic, SK Bioscience, Sangamo, Sanofi CureVac
June 11, 2025
·
6 min read
